Minimally invasive thoracic surgery is a method for performing chest surgery through small cuts, avoiding large incisions and rib spreading. Surgeons use a camera and tools to access the lung via small openings between the ribs. There are two main types of this surgery: video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery. In VATS, a thin tube called a thoracoscope with a camera is inserted through a small cut between the ribs, allowing the surgeon to see the chest cavity without fully opening it. The surgeon then removes lung tissue using specialized instruments through one or two additional small cuts. In robotic-assisted surgery, the surgeon operates from a console, controlling robotic tools and a 3D camera inserted through small incisions, allowing for precise removal of lung tissue without larger cuts.

Drivers: The need for Minimally Invasive Thoracic Surgery (MITS) is increasing due to more lung and esophageal diseases, an aging population, and a desire for less painful surgeries. MITS is used for treating lung cancer, esophageal cancer, and non-cancerous conditions, mainly in hospitals, specialty clinics, and surgical centers. Key factors for growth include advancements in surgical tools, increased healthcare spending, and greater awareness among patients and providers. Opportunities exist to expand MITS applications and increase usage in emerging markets. Recommendations include investing in research and development, partnering with healthcare organizations, and using effective marketing strategies to inform stakeholders.

Challenges: The use of minimally invasive techniques often requires large upfront investments in advanced surgical technologies, such as robotic systems and specialized tools. These systems can be expensive to buy and maintain, and they need ongoing training for staff. This financial strain can be challenging for healthcare facilities, especially in developing regions, limiting the use of these techniques. Additionally, high costs can lead to increased expenses for patients, which may make them hesitant to choose these procedures over traditional surgery, hindering market growth.

Market Trends: Minimally invasive thoracic surgeries are evolving due to advancements in laparoscopic surgery, medical robotics, and transcatheter surgery. Robotic-assisted thoracic surgery provides better accuracy and fewer complications. The da Vinci Surgical System enhances dexterity and visibility for complex procedures. In 2023, Intuitive Surgical reported increased use of its robotic systems for lung cancer surgery, helping to grow the market. Robotic systems aim for precision, lowering human error and improving patient outcomes. Non-visual imaging technologies like intraoperative CT and MRI scanning offer real-time information, benefiting patients and encouraging the use of minimally invasive techniques in thoracic surgeries.

Medtronic, Dextera Surgical Inc, Intuitive surgical Operations, Inc, Richard Wolf GmBH Grena Ltd, Medela, LivaNova PLC, Teleflex Incorporated, and Sklar Surgical Instruments are just a few of the major market players that are thoroughly examined in this market study along with revenue analysis, market segments, and competitive landscape data.

By Type: Based on the Type, Global Minimally Invasive Thoracic Surgery Market is segmented as; Lobectomy, Wedge Resection, Pneumonectomy, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.